KUALA LUMPUR: Malaysian Biotechnology Corp Sdn Bhd (BiotechCorp) expects the pharmaceutical technology park in Alor Gajah, Malacca, to attract RM1.5bil (US$500mil) in investments in the next three years.
BiotechCorp chief executive officer Datuk Dr Mohd Nazleen Kamal said that the investments would include the cost to develop the park.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!